vs
Side-by-side financial comparison of NextPlat Corp (NXPL) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $12.8M, roughly 1.4× NextPlat Corp). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -40.2%, a 37.2% gap on every dollar of revenue. On growth, NextPlat Corp posted the faster year-over-year revenue change (-21.1% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $-339.0K). Over the past eight quarters, ROCKWELL MEDICAL, INC.'s revenue compounded faster (-10.1% CAGR vs -14.4%).
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
NXPL vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.8M | $18.3M |
| Net Profit | $-5.1M | $-554.0K |
| Gross Margin | 14.3% | 21.1% |
| Operating Margin | -28.9% | -2.2% |
| Net Margin | -40.2% | -3.0% |
| Revenue YoY | -21.1% | -25.6% |
| Net Profit YoY | -70.6% | 26.7% |
| EPS (diluted) | — | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.8M | $18.3M | ||
| Q3 25 | $13.8M | $15.9M | ||
| Q2 25 | $13.2M | $16.1M | ||
| Q1 25 | $14.5M | $18.9M | ||
| Q4 24 | $16.2M | $24.7M | ||
| Q3 24 | $15.4M | $28.3M | ||
| Q2 24 | $17.0M | $25.8M | ||
| Q1 24 | $17.5M | $22.7M |
| Q4 25 | $-5.1M | $-554.0K | ||
| Q3 25 | $-2.2M | $-1.8M | ||
| Q2 25 | $-1.8M | $-1.5M | ||
| Q1 25 | $-1.3M | $-1.5M | ||
| Q4 24 | $-3.0M | $-756.0K | ||
| Q3 24 | $-4.2M | $1.7M | ||
| Q2 24 | $-5.3M | $343.0K | ||
| Q1 24 | $-1.5M | $-1.7M |
| Q4 25 | 14.3% | 21.1% | ||
| Q3 25 | 19.9% | 14.3% | ||
| Q2 25 | 21.8% | 15.6% | ||
| Q1 25 | 23.8% | 16.1% | ||
| Q4 24 | 16.8% | 14.7% | ||
| Q3 24 | 23.2% | 22.0% | ||
| Q2 24 | 34.5% | 17.6% | ||
| Q1 24 | 27.8% | 13.5% |
| Q4 25 | -28.9% | -2.2% | ||
| Q3 25 | -14.5% | -9.9% | ||
| Q2 25 | -13.8% | -8.4% | ||
| Q1 25 | -10.2% | -7.2% | ||
| Q4 24 | -14.1% | -2.1% | ||
| Q3 24 | -52.1% | 6.8% | ||
| Q2 24 | -64.1% | 2.0% | ||
| Q1 24 | -10.5% | -5.8% |
| Q4 25 | -40.2% | -3.0% | ||
| Q3 25 | -15.9% | -11.0% | ||
| Q2 25 | -13.5% | -9.3% | ||
| Q1 25 | -9.2% | -8.0% | ||
| Q4 24 | -18.6% | -3.1% | ||
| Q3 24 | -27.4% | 5.9% | ||
| Q2 24 | -31.3% | 1.3% | ||
| Q1 24 | -8.5% | -7.6% |
| Q4 25 | — | $-0.01 | ||
| Q3 25 | — | $-0.05 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | $-0.05 | $-0.04 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | $-0.22 | $0.04 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | $-0.08 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.7M | $10.7M |
| Total DebtLower is stronger | $1.3M | — |
| Stockholders' EquityBook value | $17.3M | $37.0M |
| Total Assets | $27.5M | $57.1M |
| Debt / EquityLower = less leverage | 0.07× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.7M | $10.7M | ||
| Q3 25 | $13.9M | $13.6M | ||
| Q2 25 | $16.6M | $12.5M | ||
| Q1 25 | $17.7M | $11.4M | ||
| Q4 24 | $20.0M | $15.7M | ||
| Q3 24 | $20.4M | $12.3M | ||
| Q2 24 | $24.9M | $11.9M | ||
| Q1 24 | $23.5M | $6.6M |
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.2M | — | ||
| Q2 25 | $1.2M | — | ||
| Q1 25 | $1.3M | — | ||
| Q4 24 | $1.4M | — | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $1.4M | — |
| Q4 25 | $17.3M | $37.0M | ||
| Q3 25 | $21.4M | $37.0M | ||
| Q2 25 | $23.5M | $30.4M | ||
| Q1 25 | $25.3M | $31.5M | ||
| Q4 24 | $27.3M | $32.6M | ||
| Q3 24 | $22.5M | $29.1M | ||
| Q2 24 | $26.5M | $23.5M | ||
| Q1 24 | $31.2M | $20.6M |
| Q4 25 | $27.5M | $57.1M | ||
| Q3 25 | $30.0M | $57.5M | ||
| Q2 25 | $31.0M | $52.6M | ||
| Q1 25 | $35.2M | $54.0M | ||
| Q4 24 | $37.1M | $59.2M | ||
| Q3 24 | $41.1M | $57.1M | ||
| Q2 24 | $51.5M | $53.0M | ||
| Q1 24 | $65.1M | $50.7M |
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.05× | — | ||
| Q2 25 | 0.05× | — | ||
| Q1 25 | 0.05× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.07× | — | ||
| Q2 24 | 0.05× | — | ||
| Q1 24 | 0.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-302.0K | $2.3M |
| Free Cash FlowOCF − Capex | $-339.0K | $2.2M |
| FCF MarginFCF / Revenue | -2.6% | 12.0% |
| Capex IntensityCapex / Revenue | 0.3% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-302.0K | $2.3M | ||
| Q3 25 | $-2.7M | $-1.3M | ||
| Q2 25 | $-1.0M | $1.8M | ||
| Q1 25 | $-2.1M | $-3.5M | ||
| Q4 24 | $-476.0K | $865.0K | ||
| Q3 24 | $-4.6M | $4.3M | ||
| Q2 24 | $2.3M | $1.4M | ||
| Q1 24 | $-2.7M | $-2.4M |
| Q4 25 | $-339.0K | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | $-1.1M | $1.7M | ||
| Q1 25 | $-2.1M | $-3.5M | ||
| Q4 24 | $-508.0K | $470.0K | ||
| Q3 24 | $-4.7M | $4.1M | ||
| Q2 24 | $2.2M | $1.2M | ||
| Q1 24 | $-2.7M | $-2.5M |
| Q4 25 | -2.6% | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | -8.0% | 10.5% | ||
| Q1 25 | -14.3% | -18.8% | ||
| Q4 24 | -3.1% | 1.9% | ||
| Q3 24 | -30.6% | 14.4% | ||
| Q2 24 | 13.2% | 4.5% | ||
| Q1 24 | -15.7% | -11.1% |
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 0.0% | 1.4% | ||
| Q2 25 | 0.1% | 1.0% | ||
| Q1 25 | 0.2% | 0.3% | ||
| Q4 24 | 0.2% | 1.6% | ||
| Q3 24 | 0.6% | 0.7% | ||
| Q2 24 | 0.4% | 1.1% | ||
| Q1 24 | 0.4% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NXPL
| Healthcare Operations | $9.0M | 70% |
| Ecommerce Revenue | $3.8M | 30% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
